Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$81,330,801
+$7,136,916 QoQ
Shares Held
323,203
-5.3% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#286
of 4,153 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GLENMEDE TRUST CO NA holds $996,376,961 across 14 Drug Manufacturers - General names. ABBV ranks #3 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
300,851 | $360,849,743 | |
| 2 | JNJ |
Johnson & Johnson
|
1,286,261 | $326,671,705 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
323,203 | $81,330,801 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,084,726 | $62,501,910 | |
| 5 | MRK |
Merck & Co., Inc.
|
391,031 | $50,247,482 | |
| 6 | AMGN |
Amgen Inc
|
104,523 | $37,849,868 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
199,749 | $25,236,288 | |
| 8 | PFE |
Pfizer Inc
|
793,315 | $19,103,024 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $81,330,801 | 323,203 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $74,193,885 | 341,137 | Shares | Defined | 2026-05-26 | |
| 2025-12-31 | $78,834,075 | 345,022 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $75,992,274 | 362,697 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $63,842,456 | 359,271 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $91,006,484 | 460,839 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $79,276,543 | 462,200 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $84,789,218 | 465,619 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $87,791,434 | 566,506 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $66,472,262 | 445,943 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $57,811,699 | 429,093 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $68,384,550 | 429,093 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $70,006,542 | 433,182 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $59,941,675 | 446,626 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $68,035,049 | 444,209 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $72,804,573 | 449,106 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $61,664,951 | 455,428 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $50,435,805 | 467,561 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $53,120,235 | 471,593 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $52,019,730 | 480,685 | Shares | Defined | 2021-05-18 | |
| 2020-12-31 | $51,653,906 | 482,071 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $44,718,372 | 510,542 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $102,881,837 | 1,047,890 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $43,038,739 | 564,887 | Shares | Defined | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||